Figshare
open access
CC BY-NC 4.0
Fucoidan Alleviates Intestinal Inflammation through Microbiota-Associated Citraconic Acid Accumulation to Modulate Ferroptosis-Related Pathways
Fucoidan has shown potential for intestinal protection; however, its underlying mechanisms remain unclear. This study investigated the protective effects of fucoidan against DSS-induced colitis and explored microbiota-associated metabolic changes that were linked to its protective effects. Fucoidan
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Ulcerative Colitis on Advanced Therapies#1045103
- Probiotic for Osteoarthritis#842215
- Microbiota: Its Role in Chronic Inflammation, IDB and Risk of Colorectal Cancer. Evaluation of a Predictive Prognostic Model With Therapeutic Implications#1033017
- Protease-serpin-microbiome interactions in inflammatory bowel disease: toward integrated biomarkers of gut health.#646466
- Protease-serpin-microbiome interactions in inflammatory bowel disease: toward integrated biomarkers of gut health.#645296
Record · ID 1133657
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive